Researchers have developed a high-throughput screen methodology to identify compounds affect a key G protein coupled receptor (GPCR) rhodopsin (Rh). GPCRs mediate many important physiological functions and are considered to be one of the most effective therapeutic targets for a broad spectrum of diseases, ranging from diabetes to immune system disorders.
New screening process could lead to next-generation therapeutics for a broad spectrum of diseases
- ScienceDaily
- 16. 11 2021 (23:50)